3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]苯基]-4-苯基-(4S)-2-恶唑烷酮

3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]苯基]-4-苯基-(4S)-2-恶唑烷酮性质、用途与生产工艺

3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]苯基]-4-苯基-(4S)-2-恶唑烷酮 上下游产品信息

上游原料

下游产品

3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]苯基]-4-苯基-(4S)-2-恶唑烷酮 生产厂家

272778-12-8, 3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]苯基]-4-苯基-(4S)-2-恶唑烷酮 相关搜索:

• pharmaceutical
• Ezetimibe
• Ezetimibe intermediates
• 原料药
• 柏锦生物
• 医用原料
• 医药原料
• 杂质对照品
• 对照品-杂质对照品
• 活性药物中间体
• 依泽替米贝中间体
• C39H46F2N2O5Si2
• (4S)-3-{(2R,5S)-5-(4-氟苯基)-2-[(S)-4(氟苯基)氨基][4-(三甲基硅氧基)苯基]甲基}-1-氧代-(5-三甲基硅氧基)戊基-4-苯基-2-恶唑烷酮
• 3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]?
• S) -3-((2R,5S)-5-(4-氟苯基)-2-((S)-((4-氟苯)氨基)(4-(三甲基甲硅烷基)氧基)苯基)甲基)-5-((三甲基乙硅烷基)氧化基)戊酰基)-4-苯基恶唑烷-2-酮
• 3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]苯基]-4-苯基-(4S)-2-噁唑烷酮
• (4S)-3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基)氨基]({4-[(三甲基硅)氧]苯基})甲基]-5-[(三甲基硅)氧]正戊酰基]-4-苯基-1,3-恶唑烷-2-酮
• (S)-3-((2R,5S)-5-(4-氟苯基)-2-((S)- (4-氟苯基氨基)(4-(三甲基硅氧基)苯基)甲基)-5-(三甲基硅氧基) 氧代戊基) -4-苯基-2-恶唑烷酮
• 依泽替米贝杂质9
• 依折麦布杂质68
• 依折麦布I杂质
• 依折麦布杂质9
• (4S)-3-{(2R,5S)-5-(4- 氟苯基 )-2-[(S)-(4- 氟苯基 ) 氨基 ][4-( 三甲基硅氧基 ) 苯基 ] 甲基 }-1- 氧代 -(5- 三甲基硅氧基 ) 戊基 ]-4- 苯基 -2- 噁唑烷酮
• 依折麦布中间体一
• 依替米贝中间体X
• 3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-
• 3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基(氨基)]][4-(三甲基硅)氧]苯基]甲基]-1-氧代-5-[(三甲基硅)氧]苯基]-4-苯基-(4S)-2-恶唑烷酮
• 272778-12-8
• 3-{(2R,5S)-5-(4-Fluoro-phenyl)-2-[(S)-(4-fluoro-phenylamino)-(4-trimethylsilanyloxy-phenyl)-methyl]-5-trimethylsilanyloxy-pentanoyl}-4(S)-phenyl-oxazolidin-2-one
• 3-((2R,5S)-5-(4-fluorophenyl)-2-(S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-1-((trimethylsilyl)oxy)pentyl)-4-phenyl-(4S)-2-oxazolidinone
• Ezetimibe TMS intermediate
• {2-[3-(Fluorophenyl)-3-(trimethyl silyloxy)-propyl]-3-(4- fluoro phenyl amino) -3-(4-trimethyl silyloxy phenyl)-1- oxo-propyl}-4-(S) phenyl oxazolidin-2-one
• 3-[(2R,5S)-5-(4- fluorophenyl) -2-[(S)-[(4- fluorophenyl (amino) ]][4- (trimethylsilyl) oxy] phenyl] methyl ]-1- oxo -5-[ (trimethylsilyl) oxy] phenyl
• Ezetimibe Impuriry 9
• 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)...
• 4S3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]- oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
• 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone USP/EP/BP
• Ezetimibe Impurity 68 USP/EP/BP
• Ezetimibe INT 1
• ]-oxy]phenyL
• y)-oxy]pentyL
• 3-[(2R,5S)-5-(4-FL
• ]-1-oxo-5-[(trimethyL
• )-2-[(S)-[(4-fL
• (amino)]][4-[trimethyL
• -(4S)-2-oxazoL
• 3-[2-[(4-fluoroanilino)-(4-trimethylsilyloxyphenyl)methyl]-5-(4-fluorophenyl)-1-oxo-5-trimethylsilyloxypentyl]-4-phenyl-2-oxazolidinone
• Ezetimibe Impurity 68
• (4S)-3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino]-(4-trimethylsilyloxyphen yl)methyl]-5-trimethylsilyloxy-pentanoyl]-4-phenyl-1,3-oxazolidin-2-one
• 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S
• 3-[(2R,5S)-5-(4-fluorophenyl)-2-{(S)-[4-fluorophenyl]Amino}[4-(trimethylsily)-oxy]pentyl]methyl-1-2oxo-5-(trimethylsilyl)-oxo]penyl]-4-phenyl-(4S)-2-oxazolidinon
• Ezetimibe inter-X
• (4R)-3-[(2S,5R)-5-(4-Fluorophenyl)-2-[(R)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]meth
• Ezetimibe Intermediate X
• ZT-6
• Ezetimibe Impurity 9
• (4R)-3-[(2S,5R)-5-(4-Fluorophenyl)-2-[(R)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone
• 3-(2R,5S)-5-(4-fluorophenyl)-2-(S)-(4-fluorophenyl(amino)4-trimethylsilyl-oxyphenylmethyl-1-oxo-5-(trimethylsily)-oxypentyl-4-phenyl-(4S)-2-oxazolidinone